June Lee's Net Worth
$736 Thousand
Who is June Lee?
June Lee does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include , Tenaya Therapeutics, Inc., MyoKardia Inc, and Eledon Pharmaceuticals, Inc..
SEC CIK
June Lee's CIK is 0001696493
Past Insider Trading and Trends
2018 was June Lee's most active year for acquiring shares with 21 total transactions. June Lee's most active month to acquire stocks was the month of January. 2018 was June Lee's most active year for disposing of shares, totalling 14 transactions. June Lee's most active month to dispose stocks was the month of August. 2018 saw June Lee paying a total of $631,482.54 for 114,424 shares, this is the most they've acquired in one year. In 2019 June Lee cashed out on 54,284 shares for a total of $1,395,663.99, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Tenaya Therapeutics, Inc. (TNYA) Snapshot price: $2.35
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MyoKardia Inc No price found
EVP, Chief Development Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +433.52% | 18K |
$11.95 | $215,147.80 | 22.16K |
May 2 - Feb 25
| |||
Form 4
| -9.30% | -426.00 |
$35.73 | -$625,855.41 | 4.15K |
Scheduled
|
Sep 23
| ||
Form 4
|
—
|
0
|
$34.52 | -$245,305.46 | 4.58K |
Scheduled
|
Sep 19
| ||
Form 4
|
—
|
0
|
$34.48 | -$205,666.94 | 4.58K |
Scheduled
|
Aug 9
| ||
Form 4
| +9.60% | 401 |
$40.78 | $16,353.98 | 4.58K |
Apr 30
| |||
Form 4
| +72.64% | 1.76K |
$11.95 | $21,008.10 | 4.18K |
Mar 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 4
| -31.25% | -1.10K |
$44.06 | -$48,467.43 | 2.42K |
Jan 7
| |||
Form 4
| +357.14% | 2.75K |
—
|
—
| 3.52K |
Jan 1
| |||
Form 4
| +2,428.17% | 10.34K |
$36.57 | $378,312.84 | 770 |
Scheduled
|
Oct 31 - Dec 3
| ||
Form 4
|
—
|
0
|
$37.54 | -$255,902.20 | 426 |
Scheduled
|
Sep 21
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
|
∞
| 426 |
$33.15 | $14,121.90 | 426 |
Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Eledon Pharmaceuticals, Inc. (ELDN) Snapshot price: $2.664
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||